BioELife Corp.

OTC: LITH · Healthcare · Drug Manufacturers - Specialty & Generic

PublicHQ Seal Beach, CA · OrangeCIK 0001396054Reports USD

#1166 of 1,422 Healthcare companies by revenue

EA Score

——

FH —DQ 14GM —SS 24

v0.1 · 25/100 weight · pillars only

↑ listing tenure, balance-sheet leverage · ↓ workforce scale, Piotroski F

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$337.0k

Employees

as of 2026-07-12

Market cap

$941

as of 2026-07-12

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$0$02013

Net income-$337.0k-$337.0k2018

Operating income-$73.7k-$73.7k2018

Total assets$140.0k$140.0k2018

Liabilities$321.7k$321.7k2016

Equity-$325.2k-$325.2k2018

Revenue trend

FY2011 – FY2013 · USD

FY11

FY12

FY13

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is BioELife Corp.’s revenue?

BioELife Corp. booked $0 in FY2013 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.

Peers · Healthcare

Grupo International Inc.——Omnimmune Holdings, Inc.——TetraLogic Pharmaceuticals Corporation——Rapid Therapeutic Science Laboratories, Inc.——North Bud Farms Inc.——OncoSec Medical Incorporated——

Neighbors

Orange →

Edwards Lifesciences Corporation$6.1B86A Chipotle Mexican Grill, Inc.$11.9B77B+Rivian Automotive, Inc.$5.4B38D TTM Technologies, Inc.$2.9B73B American Healthcare REIT, Inc.$2.1B56C The Ensign Group, Inc.$5.0B80B+

Key facts

CEOMichael Terpin

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersSeal Beach, CA

ExchangeOTC: LITH

Employees1

IPO date2009-08-07

Latest filings

8-K2020-05-06 8-K2020-04-17 8-K2020-04-07 8-K2020-04-02 8-K2020-03-27 8-K2020-03-09 8-K2020-02-11 8-K2020-02-06

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.